Hyper - more than normal
mobility - ability to move
Hypermobility is typically considered a dominant trait, which means that it only requires one copy of the gene associated with hypermobility to be expressed. However, there can be variations in the inheritance pattern depending on the specific underlying genetic cause of hypermobility.
Hypermobility is when your joints extend further than they are supposed to and it can cause sever chronic(non-stop) pain.
Yes
Yes, hypermobility can be inherited. It often runs in families due to genetic factors that affect connective tissue and joint laxity. Conditions like Ehlers-Danlos syndrome, which includes hypermobility as a characteristic, have a clear genetic basis, indicating that hypermobility can be passed down through generations. However, the exact inheritance patterns can vary among individuals.
This unusual flexibility is called hypermobility.
Yes, hypermobility is often a lifelong condition. While some individuals may experience changes in their joint laxity over time, the underlying tendency for hypermobility tends to persist into adulthood. Management strategies such as physical therapy and strength training can help improve symptoms and reduce the impact of hypermobility on daily life.
Hypermobility.
hypermobility. your welcome :)
Joints with a wider range of motion than people without hyperbility syndrome. Due to extra collegen (connective tissue) protein in one's joints, tendons, ligaments. Difference between hypermobility and hypermobility syndrome is latter can include persistent moderate to severe pain due to osteoarthritis and/or fibromyalgia. Sometimes a mitral valve prolapse is found too.
The term "double joint" is a misnomer. There is no such medical condition as having double joints. It likely refers to having hypermobility in the joints, a condition known as joint hypermobility syndrome.
EDS (Ehlers-Danlos syndrome) is a group of genetic connective tissue disorders that affect the skin, joints, and blood vessels, leading to hypermobility and tissue fragility. ERS (Ehlers-Danlos syndrome hypermobility type) is a subtype of EDS that specifically manifests with joint hypermobility and related symptoms without significant skin or tissue involvement.
Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) primarily used to relieve pain and inflammation. While it can help manage symptoms associated with hypermobility, such as joint pain and discomfort, it does not treat the underlying condition itself. It's important for individuals with hypermobility to consult a healthcare professional for a comprehensive management plan that may include physical therapy and other interventions.